
Sign up to save your podcasts
Or


Bethany Samuelson Bannow, MD, Director of Classical Hematology at Cleveland Clinic, joins the Cancer Advances podcast to discuss the evolving field of classical hematology and what it means for managing complex non-malignant blood diseases. Listen as she covers emerging gene therapies, bispecific antibodies, cancer-associated thrombosis, and practical referral guidance for conditions like ITP, TTP, and sickle cell disease.
By Cleveland Clinic Cancer Institute5
2424 ratings
Bethany Samuelson Bannow, MD, Director of Classical Hematology at Cleveland Clinic, joins the Cancer Advances podcast to discuss the evolving field of classical hematology and what it means for managing complex non-malignant blood diseases. Listen as she covers emerging gene therapies, bispecific antibodies, cancer-associated thrombosis, and practical referral guidance for conditions like ITP, TTP, and sickle cell disease.

2,155 Listeners

547 Listeners

2,056 Listeners

295 Listeners

369,836 Listeners

7,978 Listeners

47,392 Listeners

29,263 Listeners

20,492 Listeners

17,168 Listeners